Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Subject
01 ENOXAPARIN SODIUM USP (1)
02 HEPARIN SODIUM (1)
03 NADROPARIN CALCIUM (1)
Holder
01 SHANDONG CHENZHONG BIOPHARMACEUTICAL CO LTD (3)
Country
01 China (3)
Status
01 Active (3)
GDUFA DMF Review
01 Blank (3)